Alpha 1 -antitrypsin (a 1 -AT) is the most abundant circulating inhibitor of serine proteases and therefore is essential to normal protease±anti-protease homeostasis. Inheritance of two parental a 1 -AT de®ciency alleles is associated with a substantially increased risk for development of emphysema and liver disease. In very rare circumstances individuals may inherit a 1 -AT null alleles. Null a 1 -AT alleles are characterized by the total absence of serum a 1 -AT. These alleles represent the extreme end in a continuum of alleles associated with a 1 -AT de®ciency. The molecular mechanisms responsible for absence of serum a 1 -AT include splicing abnormalities, deletion of a 1 -AT coding exons and premature stop codons. While these alleles comprise only a small proportion of a 1 -AT alleles associated with profound a 1 -AT de®ciency, studies of their molecular mechanisms provide valuable insights into the structure, gene expression and intracellular transport of a 1 -AT.
Background
The a 1 -antitrypsin (a 1 -AT) gene locus is designated PI and has been mapped to 14q32.1, near the immunoglobulin heavy chain gene cluster (1±5). It resides in a gene cluster which includes cortisol binding globulin, a 1 -antichymotrypsin, a 1 -AT pseudogene and protein C inhibitor ( Fig. 1 ) (1±5). The a 1 -AT gene is composed of seven exons spanning 12 kb (Fig. 2 ) (1±6). The transcription and translation of a 1 -AT is similar to other secreted glycoproteins. Transcriptional regulation occurs in at least two dierent sites within the gene and modulation factors include several liver speci®c factors and cytokines including IL-1b and IL-6 and TNFa (2, 3) . Translation of a 1 -AT mRNA results in a 418 amino acid protein, including a 24 amino acid signal peptide (1±6). In the rough endoplasmic reticulum membrane the signal peptide is cleaved from the polypeptide and glycosylation begins during protein folding. After transport to the cis-golgi the carbohydrate sidechains are trimmed and complex residues are added. Following processing in the golgi, the 52 kDa globular glycoprotein is rapidly secreted into the serum. While the principal site of synthesis is the liver parenchymal cell, a 1 -AT synthesis also occurs in mononuclear phagocytes, intestinal epithelium, kidney parenchyma and several other sites (2±5). a 1 -AT de®ciency, a common autosomal recessive inherited disease among Caucasians, is characterized by reduction in serum a 1 -AT in association with emphysema and, occasionally, liver disease. Most individuals with a 1 -AT de®ciency are homozygous for the PI*Z allele (1±5). Approximately 5% of a 1 -AT de®cient individuals have other de®ciency alleles including those associated with low a 1 -AT serum levels or null alleles which do not express a 1 -AT (2,4,5,7). Null alleles, while rarely causing a 1 -AT de®ciency, represent an opportunity to understand the relationship between gene sequence changes and mechanisms of a 1 -AT expression. The various a 1 -AT null alleles result from several dierent molecular mechanisms, including large gene deletions, intron mutations, nonsense mutations, frameshift mutations, and missense mutations associated with amino acid substitutions in potentially critical structural elements (2,4,5,7±21) ( Table 1) . Interestingly, and in contrast to the b thalassaemias, no mutations in the promotor regions of the a 1 -AT gene have been reported in association with the complete absence or partial de®ciency of a 1 -AT.
Null alleles as a result of large gene deletions
The existence of a 1 -AT null alleles was ®rst noted in the early 1970s by several investigators. Complete deletions of the a 1 -AT gene are rare and comprise only a small fraction of the total number of null alleles. The ®rst documented complete deletion of the coding regions of a 1 -AT was QOisola di procida (8) . conserved nucleotide position in vertebrate splice donor sites. Metabolic labeling of NIH-3T3 cells transfected with a plasmid vector containing an a 1 -AT minigene with the QOwest mutation demonstrated an absence of detectable immunoprecipitable a 1 -AT, con®rming that the G to T mutation is responsible for the observed null phenotype. QOwest a 1 -AT minigene transfected cells expressed 25±100 fold less a 1 -AT mRNA than a normal control. DNA sequencing of polymerase chain reaction ampli®ed mRNA obtained from transfected cells demonstrated a cryptic splice site 84 bases upstream from the normal splice site. Translation of this sequence would result in an in-frame deletion of amino acids Gly 164 to Lys 191 , corresponding structurally to a-helix F and b-sheet 3A of the a 1 -AT protein (18, 19) . QObonny blue is a deletion of a guanine at position 1 of the exon II splice acceptor site (7). The molecular consequences of this mutation have not been reported.
Null alleles associated with formation of premature termination codons
Among the a 1 -AT null mutations caused by formation of premature stop codons, molecular mechanisms have been de®ned for variants with no detectable mRNA (QOgranite falls and bellingham) and alleles which produce normal mRNA levels (QOhong kong, mattawa, bolton, and clayton/saarbruecken) (Table 2) (9±11,13±17, 21, 22) . While QOgranite falls, QObellingham and QOtrastevere terminate in exon II and III, the rest of the mutations cause the formation of termination codons in exon V, near the N-terminus of the protein. The observation that mutation-caused premature termination codons near the end of a coding sequence are associated with normal mRNA content and mutations in the early coding sequence are associated with decreased steady-state cytoplasmic mRNA is consistent with the translational± translocation model (22±24). In this model, translation of the mRNA on the ribosome starts as soon as the mRNA emerges from the nuclear pore. Mutations that cause premature termination codons would halt the pulling process, leaving the RNA molecule vulnerable to RNase digestion. However mutations occurring after the penultimate exon would not be recognized until the translocation of the mRNA from the nucleus was almost complete and, therefore, would not be associated with decreased mRNA content (22±25).
Nonsense mutations in several genes have been reported to decrease steady state mRNA levels (22, 23) . Several possible explanations exist, including lowering the transcription rate, reducing the rate of RNA processing and/or causing unstable mature mRNA (22, 23) . Evaluation of nonsense mutants in other genes however, has not demonstrated signi®cant lowering of the transcription rate. There are several examples which illustrate the critical role of mRNA stability in determining levels of gene expression. Elements of the RNA structure including the cap structure, 5'UTR secondary structures, premature termination codons, open reading frame sequences, 3'UTR sequences and the poly (A) tail all may contribute to mRNA stability (22, 23) . Alteration in the secondary structure of mRNA does not appear to aect stability. Since most missense mutants do not show the low mRNA phenotype, and revertants of low mRNA nonsense mutants show normal mRNA levels, it is possible that the functional consequence of a nonsense codon itself is a decreased mRNA level (22, 23) . The position of premature termination codons in the a 1 -AT coding sequence clearly has an important eect on the a 1 -AT mRNA level (Table 2) . QOgranite falls, which has a premature termination at exon II, does not express mRNA, whereas QOhong kong, QOmattawa, QObolton and QOclayton have termination codons in exon V and near normal mRNA levels (Table 2) . When a premature termination codon is positioned between these extremes, as in the case of QOtrastevere, mRNA expression is reduced. In general, a 1 -AT mRNA cellular content depends on the distance of the nonsense codon from the initiator codon (22±24). QObellingham appears to be an exception to this observation since this allele is associated with total absence of detectable mRNA and despite the presence of its termination codon is 3' to the QOtrastevere stop codon. This observation demonstrates that some elements within the coding region may be more important than others in conferring mRNA stability. Thus, a 1 -AT mRNA stability is not simply a function of the distance of a nonsense mutation from the initiator codon (22, 23) . The eect of a 1 -AT nonsense mutations, speci®cally the QOtrastevere mutation, on mRNA levels is consistent with the translocation/translation explanation of nonsense mutations on mRNA stability (22) .
Similar to other truncated a 1 -AT variants, the QOtrastevere mutant protein is retained in the rough endoplasmic reticulum (RER)/pre-Golgi compartment and rapidly degraded. Although there is a substantial dierence in the degree of truncation of QOtrastevere (193 amino acids) and QOhong kong (333 amino acids), QOtrastevere has a half-life similar to that of QOhong kong (t 1/2 =2 h) rather than that of QOclayton (t 1/2 =6?5 h) which has 375 amino acids (Table 2) (17) . This observation indicates that disposal of truncated a 1 -AT may involve determinants not speci®cally related to the degree of truncation. Similar to Z a 1 -AT, QOtrastevere a 1 -AT degradation was inhibited by the translation inhibitor cycloheximide, but is not inhibited by agents that disrupt lysosomal function (17,26±28). However, while Z a 1 -AT degradation was inhibited by the metabolic poisons, NaN 3 /NaF or 2,4-dinitrophenol/2-deoxy-D-glucose, QOtrastevere degradation was only inhibited by NaN 3 /NaF, indicating that dierent pathways of intracellular degradation may exist for some truncated and misfolded proteins (17,26±28) .
With the exception of promoter mutations, a 1 -AT null mutations re¯ect most mechanisms currently known to be associated with the complete absence of a single gene product. Observations made as a result of these experiments in nature may prove valuable in understanding the molecular basis of liver disease and expand our general knowledge of quality control mechanism-associated disposal of misfolded proteins. 
